Insider · CIK 0001435388

Clark B. Jefferson

Reports to the SEC for 2 companies · CARY, NC

sec.gov

Transactions

Companies

Filings

CIK

0001435388

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-01-01	Tobira Therapeutics, Inc.Common Stock (right to buy)A Award	Director	AAward	+159K sh	—	—	159,261
2014-02-20	Tobira Therapeutics, Inc.Warrant (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−1 sh	—	—	0
2014-02-20	Tobira Therapeutics, Inc.Stock Option (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−1 sh	—	—	0
2014-02-20	Tobira Therapeutics, Inc.Stock Option (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−1 sh	—	—	0
2014-02-20	Tobira Therapeutics, Inc.Stock Option (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−1 sh	—	—	0
2014-02-20	Tobira Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+4,491 sh	$0.17	+$763.47	1,130,133
2014-02-20	Tobira Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+3,341 sh	$4.51	+$15.1K	1,125,642
2014-02-20	Tobira Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+2,095 sh	$3.34	+$6,997.3	1,116,854
2014-02-20	Tobira Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+5,447 sh	$4.51	+$24.6K	1,122,301
2014-01-01	Tobira Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,640 sh	—	—	9,640
2013-08-27	Tobira Therapeutics, Inc.Series B Preferred StockC Conversion	Director	CConversion	−1.46M sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Series C Preferred StockC Conversion	Director	CConversion	−2.22M sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Series D Preferred StockC Conversion	Director	CConversion	+5.38M sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Series E Preferred StockC Conversion	Director	CConversion	−808K sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Series A Preferred StockC Conversion	Director	CConversion	−2.43M sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	17,964
2013-08-27	Tobira Therapeutics, Inc.P Purchase	Director	PPurchase	+359K sh	$4.00	+$1.44M	1,114,759
2013-08-27	Tobira Therapeutics, Inc.C Conversion	Director	CConversion	+48.4K sh	—	—	755,449
2013-08-27	Tobira Therapeutics, Inc.C Conversion	Director	CConversion	+322K sh	—	—	707,087
2013-08-27	Tobira Therapeutics, Inc.C Conversion	Director	CConversion	+133K sh	—	—	385,114
2013-08-27	Tobira Therapeutics, Inc.C Conversion	Director	CConversion	+87.3K sh	—	—	252,047
2013-08-27	Tobira Therapeutics, Inc.C Conversion	Director	CConversion	+145K sh	—	—	164,722

Recent filings

Accepted (ET)
Jan 54
Regado Biosciences Inc0001209191-15-001355
SEC(opens sec.gov)
Mar 34
Regado Biosciences Inc0001140361-14-010646
SEC(opens sec.gov)
Jan 34
Regado Biosciences Inc0001140361-14-000617
SEC(opens sec.gov)
Aug 294
Regado Biosciences Inc0001140361-13-034586
SEC(opens sec.gov)

Companies

Address

790 SE CARY PARKWAY, SUITE 204

CARY, NC, 27511